AIM
AGN

Acrospire Investment Management’s Allergan plc AGN Stock Holding History

Acrospire Investment Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-32
Closed -$8K – 2705
2017
Q1 		$8K Sell
32
-100
-76% -$23.3K 0.01% 1923
2016
Q4 		$28K Buy
+132
New +$27.3K 0.01% 1661

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Acrospire Investment Management's AGN Position: Q2 2017 in Review

Acrospire Investment Management sold out of Allergan plc (AGN) in Q2 2017, closing a stake of 32 shares — an estimated $8K sold.

Acrospire Investment Management first reported a position in AGN in Q4 2016 and held it in 2 quarters. The position peaked at $28K in Q4 2016. 1,115 funds tracked by Wall St. Rank hold AGN as of Q2 2017.

  • Acrospire Investment Management reported no remaining Allergan plc position as of Q2 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 32 Allergan plc shares in Q2 2017, an estimated $8K.
  • Acrospire Investment Management first reported a position in Allergan plc in Q4 2016 and held it in 2 quarters.
  • Acrospire Investment Management's Allergan plc position peaked at $28K in Q4 2016.
  • 1,115 funds tracked by Wall St. Rank held Allergan plc as of Q2 2017.

Based on Acrospire Investment Management's 13F filing for Q2 2017, filed 11 Aug 2017.